These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25931264)

  • 1. Successful generation of structural information for fragment-based drug discovery.
    Öster L; Tapani S; Xue Y; Käck H
    Drug Discov Today; 2015 Sep; 20(9):1104-11. PubMed ID: 25931264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key factors for successful generation of protein-fragment structures requirement on protein, crystals, and technology.
    Böttcher J; Jestel A; Kiefersauer R; Krapp S; Nagel S; Steinbacher S; Steuber H
    Methods Enzymol; 2011; 493():61-89. PubMed ID: 21371587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures.
    Erlanson DA; Davis BJ; Jahnke W
    Cell Chem Biol; 2019 Jan; 26(1):9-15. PubMed ID: 30482678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
    Meanwell NA
    Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of hidden allosteric sites as novel targets for allosteric drug design.
    Lu S; Ji M; Ni D; Zhang J
    Drug Discov Today; 2018 Feb; 23(2):359-365. PubMed ID: 29030241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization to obtain protein-ligand complexes for structure-aided drug design.
    Danley DE
    Acta Crystallogr D Biol Crystallogr; 2006 Jun; 62(Pt 6):569-75. PubMed ID: 16699182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the fragment-based drug discovery].
    Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK
    Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of structural biology in drug discovery.
    Tari LW
    Methods Mol Biol; 2012; 841():1-27. PubMed ID: 22222446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining biophysical screening and X-ray crystallography for fragment-based drug discovery.
    Hennig M; Ruf A; Huber W
    Top Curr Chem; 2012; 317():115-43. PubMed ID: 21837555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.
    Cavalluzzi MM; Mangiatordi GF; Nicolotti O; Lentini G
    Expert Opin Drug Discov; 2017 Nov; 12(11):1087-1104. PubMed ID: 28814111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based drug discovery and protein targets in the CNS.
    Hubbard RE
    Neuropharmacology; 2011 Jan; 60(1):7-23. PubMed ID: 20673774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray crystallography over the past decade for novel drug discovery - where are we heading next?
    Zheng H; Handing KB; Zimmerman MD; Shabalin IG; Almo SC; Minor W
    Expert Opin Drug Discov; 2015; 10(9):975-89. PubMed ID: 26177814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicinal chemistry inspired fragment-based drug discovery.
    Lanter J; Zhang X; Sui Z
    Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds.
    Stoll F; Göller AH; Hillisch A
    Drug Discov Today; 2011 Jun; 16(11-12):530-8. PubMed ID: 21554979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.